Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Biotech IPO slump seen dragging into 2026 as returns disappoint https://t.co/WQNI4VKZM8
#China and tariffs have wiped off $130 billion from critical chip firm $ASML since peak value More than $130 billion of value has been wiped off of ASML in under a year. The company, like many chip firms, has been hit by restrictions on exports to China and by U.S. tariff
China and tariffs have wiped off US$130 billion from critical chip firm ASML since peak value - CNBC https://t.co/HU6VL6RRwB
ASML Holding NV, a critical player in the semiconductor industry, has seen its market capitalization decline by more than $130 billion since its peak in July 2024. The company’s stock price dropped approximately 25% over the past year from a record high near €1,000. This decline has been attributed to export restrictions to China and the impact of U.S. tariffs on Chinese goods. These factors have collectively pressured ASML’s valuation amid ongoing geopolitical trade tensions. Separately, the biotech sector is experiencing a slump in initial public offerings, with disappointing returns expected to continue into 2026.